Symptoms of Depression
Depression: Major Depression & Unipolar Varieties
Resources
Basic Information
Introduction and Types of DepressionRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
Phone Care Can Help Combat Post-Heart Surgery DepressionClinical Trials Update: Nov. 16, 2009Depression Linked to Immune Response in PregnancyClinical Trials Update: Nov. 12, 2009Health Tip: Symptoms of Postpartum DepressionBrain Stimulation May Ease Treatment-Resistant DepressionClinical Trials Update: Nov. 9, 2009Adjunctive Psychotherapy for Depression StudiedDepression May Blur Memory of Aches and PainsCognitive Behavioral Therapy Helps Overcome Winter BluesPsychotherapy Beats Light Treatment for SADPhone Counseling for Depression Rings With PromiseDepression Often Goes Untreated in Working MomsConstant Light Linked to Symptoms of DepressionOmega-3 Augmentation of Antidepressant EvaluatedSuicidal Thoughts May Vary by AntidepressantImpact of Maternal Depression and Abuse on Children StudiedRecession Adds to Ranks of Americans With DepressionDepression, Anxiety May Raise Odds of ObesityTelephone Care and Therapy Help to Treat DepressionMother's Use of Antidepressant May Carry Risks for NewbornTroubled Minds Can Mean Wider WaistlinesTeens With ADHD, Depression Risk Internet AddictionAntidepressants May Be Linked to Birth ProblemsMediterranean Diet May Help Prevent DepressionAntidepressants Linked to Heart Defects in NewbornsPredicting Postpartum Depression May Be PossibleDrinking, Weight, Depression Linked in Young Women: StudyHealth Care Assistants May Be Useful in Depression CareDepression May Hasten Cancer DeathStudies Explore Genetic Factors Underlying DepressionSevere, Lasting Depression Tied to Heart Patient DeathsDepressed Teens Continue to Suffer into AdulthoodReport Addresses Depression Management in PregnancyDepression's Effect on Pleasure Is RealForeclosures Plunge People Into DepressionSuicide Risk With Antidepressants Falls With AgeCombo Treatment May Ease Depression After StrokeAntidepressant Use in U.S. Has Almost DoubledCan Children Headed for Teen Depression Be Spotted Early?Primary Care Identification of Depression ExaminedGloomy Days Dim Cognitive Powers of the DepressedDepression Poses Pregnancy RisksDepression, Anxiety Bad for the HeartStudy Refutes Depression Gene FindingDrug May Stem Slide Into Alzheimer's for SomeEffects of Depression on Families Need to Be AddressedIf Mom or Dad Is Depressed, Kids Need Help TooEarly Bedtime May Help Stave Off Teen DepressionNew Program May Help Teens at High Risk for Depression
Questions and AnswersBlog EntriesVideosLinksBook ReviewsSelf-Help Groups
Community

Talk about this issue in our mental health support community

Therapist Search
Find a Therapist:
 (USA/CAN only)

Use our Advanced Search to locate a therapist outside of North America.

Related Topics

Anxiety Disorders
Bipolar Disorder
Suicide
Addictions: Alcohol and Substance Abuse
Pain Management
View the Depression Primer - an illustrated book about Depression

Omega-3 Augmentation of Antidepressant Evaluated

(HealthDay News)
by -- Jeff Muise
Updated: Oct 20th 2009

new article illustration

TUESDAY, Oct. 20 (HealthDay News) -- Giving omega-3 fatty acids along with sertraline to patients with depression and coronary heart disease (CHD) did not augment the effect of the antidepressant, according to a study in the Oct. 21 issue of the Journal of the American Medical Association.

Robert M. Carney, Ph.D., of the Washington University School of Medicine in St Louis, and colleagues randomized 122 patients with major depression and CHD to a regimen of 50 mg/d of the selective serotonin reuptake inhibitor sertraline and either 2 g/d of omega-3 acid ethyl esters (930 mg of eicosapentaenoic acid [EPA] and 759 mg of docosahexaenoic acid [DHA]) or placebo for a period of 10 weeks. The main outcome measures were scores on the Hamilton Rating Scale for Depression (HAM-D) or the Beck Depression Inventory (BDI-II).

The researchers reported no significant differences between the groups taking omega-3 or placebo in weekly BDI-II or HAM-D scores, in 10-week mean BDI-II or mean HAM-D scores, nor in any of the indicators of depression remission or response.

"Treatment of patients with CHD and major depression with sertraline and omega-3 fatty acids did not result in superior depression outcomes at 10 weeks, compared with sertraline and placebo. Whether higher doses of omega-3 or sertraline, a different ratio of EPA to DHA, longer treatment, or omega-3 monotherapy can improve depression in patients with CHD remains to be determined," the authors write.

GlaxoSmithKline supplied the omega-3 and placebo capsules and Pfizer supplied the sertraline. Two of the study authors reported receiving honoraria, speaker fees, or advisory fees from, or having stock in, pharmaceutical companies.

Abstract
Full Text

Follow us on Twitter!

Find us on Facebook!





powered by centersite dot net